Gilteritinib hemifumarate

Item number	Size	Delivery time	Price
TGM-T71973-1mg	1 mg	7 - 10 business days*	34.00€
TGM-T71973-5mg	5 mg	7 - 10 business days*	78.00€
TGM-T71973-10mg	10 mg	7 - 10 business days*	119.00€
TGM-T71973-25mg	25 mg	7 - 10 business days*	193.00€
TGM-T71973-50mg	50 mg	7 - 10 business days*	282.00€
TGM-T71973-100mg	100 mg	7 - 10 business days*	445.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Gilteritinib hemifumarate (ASP2215 hemifumarate) is a potent ATP-competitive dual... more

Close menu

Product information "Gilteritinib hemifumarate"

Description: Gilteritinib hemifumarate (ASP2215 hemifumarate) is a potent ATP-competitive dual FLT3 (IC50: 0.29 nM) and AXL (IC50: 0.73 nM) inhibitor for the treatment of relapsed or refractory FLT3 mutant AML. Target: TAM Receptor, FLT. Smiles: C(=C/C(O)=O)\C(O)=O.N(C=1C(C(N)=O)=NC(CC)=C(NC2CCOCC2)N1)C3=CC(OC)=C(C=C3)N4CCC(CC4)N5CCN(C)CC5. References: Yoko Ueno,et al. ASP2215, a novel FLT3/AXL inhibitor: Preclinical evaluation in combination with cytarabine and anthracycline in acute myeloid leukemia (AML).Journal of Clinical Oncology 2014 32:15_suppl, 7071

Keywords:	ASP2215 hemifumarate
Supplier:	TargetMol
Supplier-Nr:	T71973

Properties

Application:	Targets fms-related tyrosine kinase 3 [EC:2.7.10.1] (FLT3, FLK2, CD135)
MW:	610.75 D
Formula:	C29H44N8O3.1/2C4H4O4

Database Information

CAS :	1254053-84-3\| Matching products
KEGG ID :	K05092 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Gilteritinib hemifumarate"

Write a review